Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections.

July 28, 2013 at 2:58 pm

Virulence. 2011 Mar-Apr;2(2):97-102.

Mihu MR, Martinez LR.

Source

Department of Medicine, Sound Shore Medical Center of Westchester, New Rochelle, NY, USA.

Abstract

The Gram-negative coccobacillus Acinetobacter baumannii (Ab) has become an increasingly prevalent cause of hospital-acquired infections during the last two decades primarily resulting in pneumonia and complicated infections, including wound infections in troops injured in Afghanistan and Iraq. Moreover, the majority of clinical Ab isolates display high-level resistance to commonly utilized antimicrobial drugs, which severely compromises our capacity to care for patients with Ab disease. Thus, radically new approaches are urgently needed. This review focuses on novel therapies that can challenge the evolving ability of Ab to develop resistance and cause disease.

PDF

http://www.landesbioscience.com/journals/virulence/MihuVIRU2-2.pdf

 

 

Acinetobacter baumannii, nosocomial infections, multidrug-resistant, antimicrobial therapy

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Epidemiología, Infecciones en piel y tej blandos, Metodos diagnosticos, Resistencia bacteriana, REVIEWS, Sepsis.

Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Edema palpebral como expresión oligosintomática de Mononucleosis Infecciosa


Calendar

July 2013
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  

Most Recent Posts


%d bloggers like this: